Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Clinical and Diagnostic Research : JCDR
|
January 14, 2015
Diffuse hypopigmentation followed by hyperpigmentation in an african american woman with hemangiopericytoma treated with dasatinib
Karim Boudadi, Rashmi Chugh
Clinical Medicine Insights. Oncology
|
March 26, 2016
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
Karim Boudadi, Emmanuel S Antonarakis
Behavioral Neuroscience
|
January 28, 2009
Multiple learning parameters differentially regulate olfactory generalization
Thomas A Cleland, Venkata Anupama Narla, Karim Boudadi
Oral Oncology
|
August 15, 2020
The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma
Jong Chul Park, Julia Durbeck, Karim Boudadi, et al.
Radiation Oncology (London, England)
|
May 14, 2024
Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design
Emile Gogineni, Hao Chen, Chen Hu, et al.
Neurobiology of Aging
|
January 19, 2010
Compensatory responses to age-related decline in odor quality acuity: cholinergic neuromodulation and olfactory enrichment
Nathalie Mandairon, Shane T Peace, Karim Boudadi, et al.
Seminars in Oncology
|
April 2, 2013
A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer
Budhi S Yadav, Anshuma Bansal, Suresh C Sharma, et al.
Cancer Chemotherapy and Pharmacology
|
November 10, 2016
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer
Benjamin L Maughan, Daniel L Suzman, Brandon Luber, et al.
The Prostate
|
February 26, 2021
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial
Eugene Shenderov, Karim Boudadi, Wei Fu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
ICI-induced Granulomatous Sialadenitis is Responsive to Prednisone
Rachel J Kulchar, Amara Ogbonnaya-Whittlesey, Margaret E Beach, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Clinical and Diagnostic Research : JCDR
|
January 14, 2015
Diffuse hypopigmentation followed by hyperpigmentation in an african american woman with hemangiopericytoma treated with dasatinib
Karim Boudadi, Rashmi Chugh
Clinical Medicine Insights. Oncology
|
March 26, 2016
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
Karim Boudadi, Emmanuel S Antonarakis
Behavioral Neuroscience
|
January 28, 2009
Multiple learning parameters differentially regulate olfactory generalization
Thomas A Cleland, Venkata Anupama Narla, Karim Boudadi
Oral Oncology
|
August 15, 2020
The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma
Jong Chul Park, Julia Durbeck, Karim Boudadi, et al.
Radiation Oncology (London, England)
|
May 14, 2024
Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design
Emile Gogineni, Hao Chen, Chen Hu, et al.
Neurobiology of Aging
|
January 19, 2010
Compensatory responses to age-related decline in odor quality acuity: cholinergic neuromodulation and olfactory enrichment
Nathalie Mandairon, Shane T Peace, Karim Boudadi, et al.
Seminars in Oncology
|
April 2, 2013
A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer
Budhi S Yadav, Anshuma Bansal, Suresh C Sharma, et al.
Cancer Chemotherapy and Pharmacology
|
November 10, 2016
Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer
Benjamin L Maughan, Daniel L Suzman, Brandon Luber, et al.
The Prostate
|
February 26, 2021
Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial
Eugene Shenderov, Karim Boudadi, Wei Fu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 6, 2026
ICI-induced Granulomatous Sialadenitis is Responsive to Prednisone
Rachel J Kulchar, Amara Ogbonnaya-Whittlesey, Margaret E Beach, et al.
Page
of 2